These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18923415)

  • 1. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.
    Wang C; Nieschlag E; Swerdloff R; Behre HM; Hellstrom WJ; Gooren LJ; Kaufman JM; Legros JJ; Lunenfeld B; Morales A; Morley JE; Schulman C; Thompson IM; Weidner W; Wu FC
    Int J Impot Res; 2009; 21(1):1-8. PubMed ID: 18923415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current National and International Guidelines for the Management of Male Hypogonadism: Helping Clinicians to Navigate Variation in Diagnostic Criteria and Treatment Recommendations.
    Al-Sharefi A; Quinton R
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):526-540. PubMed ID: 32981295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertoli cell lysosomes and late-onset hypogonadism.
    Zamoner A; Oliveira PF; Alves MG
    Nat Aging; 2024 May; 4(5):618-620. PubMed ID: 38671231
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel Therapeutic Approach for Late-Onset Hypogonadism.
    Kam SC; Shin YS
    World J Mens Health; 2024 Jul; 42(3):658-659. PubMed ID: 38606858
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.
    Bhasin S; Cunningham GR; Hayes FJ; Matsumoto AM; Snyder PJ; Swerdloff RS; Montori VM;
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2536-59. PubMed ID: 20525905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy.
    Canu L; Sparano C; Naletto L; De Filpo G; Cantini G; Rapizzi E; Martinelli S; Ercolino T; Cioppi F; Fantoni A; Zanatta L; Terreni A; Mannelli M; Luconi M; Maggi M; Lotti F
    Front Endocrinol (Lausanne); 2023; 14():1320722. PubMed ID: 38269251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement in men with sexual dysfunction.
    Lee H; Hwang EC; Oh CK; Lee S; Yu HS; Lim JS; Kim HW; Walsh T; Kim MH; Jung JH; Dahm P
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013071. PubMed ID: 38224135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male Sex Hormones, Metabolic Syndrome, and Aquaporins: A Triad of Players in Male (in)Fertility.
    Nunes DC; Ribeiro JC; Alves MG; Oliveira PF; Bernardino RL
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of endogenous testosterone density on prostate cancer progression in patients with very favorable low and intermediate risk treated with radical prostatectomy.
    Porcaro AB; Tafuri A; Panunzio A; Cerrato C; Bianchi A; Gallina S; Vidiri S; D'Aietti D; Serafin E; Mazzucato G; Princiotta A; Brusa D; Brunelli M; Pagliarulo V; Cerruto MA; Antonelli A
    Asian J Androl; 2023 Jan; 25(5):556-63. PubMed ID: 36629157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Testosterone treatment].
    Rosellen J; Diemer T; Hauptmann A; Wagenlehner F
    Urologie; 2022 Nov; 61(11):1260-1275. PubMed ID: 36279006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis.
    Thepwiwatjit S; Charoensri S; Sirithanaphol W; Mahakkanukrauh A; Suwannaroj S; Foocharoen C
    J Scleroderma Relat Disord; 2022 Oct; 7(3):234-242. PubMed ID: 36211203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Aerobic Exercise Combined with Oyster Peptide Supplement on the Formation of CTX-induced Late-Onset Hypogonadism in Male Rats.
    Shi W; Liu Y; Jin Q; Wu M; Sun Q; Li Z; Liu W
    Reprod Sci; 2023 Apr; 30(4):1291-1305. PubMed ID: 36097247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice guideline for pharmacists: The management of late-onset hypogonadism.
    Matai A; Abdullahi M; Beahm NP; Sadowski CA
    Can Pharm J (Ott); 2022; 155(1):26-38. PubMed ID: 35035640
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men.
    Sansone A; Kliesch S; Dugas M; Sandhowe-Klaverkamp R; Isidori AM; Schlatt S; Zitzmann M
    J Endocrinol Invest; 2021 Nov; 44(11):2465-2474. PubMed ID: 33811609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hypopituitarism and quality of life in survivors of post-traumatic brain injury.
    Bensalah M; Donaldson M; Labassen M; Cherfi L; Nebbal M; Haffaf EM; Abdennebi B; Guenane K; Kemali Z; Ould Kablia S
    Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00146. PubMed ID: 32704567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age ≤40 is an independent predictor of anastomotic urethroplasty and successful repair of bulbar urethral strictures.
    Davenport MT; Wooliscroft JT; McKibben MJ; Shakir N; Fuchs JS; Yi YA; Viers BR; Bergeson RL; Ward EE; Morey AF
    Transl Androl Urol; 2020 Feb; 9(1):10-15. PubMed ID: 32055460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing Aging Male Symptom Questionnaire Through Genetic Algorithms Based Machine Learning Techniques.
    Kim JW; Moon DG
    World J Mens Health; 2021 Jan; 39(1):139-146. PubMed ID: 32009307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly.
    Cannarella R; Barbagallo F; Condorelli RA; Aversa A; La Vignera S; Calogero AE
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31581477
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive Factors of Efficacy Maintenance after Testosterone Treatment Cessation.
    Park MG; Yeo JK; Park SG; Na W; Moon DG
    J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30699978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of metabolic profile of obese men on the severity of erectile dysfunction: are metabolically healthy obese individuals protected?
    Moura A; Tomada I; Tomada N
    Turk J Urol; 2018 Nov; 44(6):455-461. PubMed ID: 30201077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.